SEC Form 3 · accession 0001144204-18-037630
ZYNEX INC · ZYXIQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Thomas Sandgaard
Officer — President, CEO and Chairman · 10% Owner
Sandgaard Holdings LLC
10% Owner
Period of report
Jul 9, 2018
Accepted (ET)
Jul 9, 2018 · 10:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000846475
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,129,571 | D | ||
| Common Stock | holding | — | — | — | 15,200,000 | I | Held by Sandgaard Holdings LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.22 | holding | — | — | — | Oct 31, 2014 | Oct 31, 2023 | A | 190,000 | — | D |
| Option to Purchase Common StockF2 | $0.14 | holding | — | — | — | Jan 2, 2016 | Jan 2, 2026 | A | 203,571 | — | D |
| Option to Purchase Common StockF3 | $2.76 | holding | — | — | — | Dec 14, 2018 | Dec 14, 2027 | A | 1,000 | — | D |
Explanation of responses
- F1Represents options to purchase 190,000 shares of the Issuer's common stock issued pursuant to the Zynex Medical Holdings Inc. 2005 Stock Option Plan (the "2005 Plan") which have vested in full.
- F2Represents options to purchase 203,571 shares of common stock issued pursuant to the 2005 Plan which have vested in full.
- F3Represents options to purchase 1,000 shares of common stock issued on December 14, 2017 pursuant to the Issuer's 2017 Stock Incentive Plan of which no options are vested and which total options vest in four equal annual installments beginning on the one year anniversary of the issue date.